Skip to main content
Journal of Virology logoLink to Journal of Virology
. 2008 Jun 11;82(16):8204–8209. doi: 10.1128/JVI.00718-08

Amino Acid 226 in the Hemagglutinin of H4N6 Influenza Virus Determines Binding Affinity for α2,6-Linked Sialic Acid and Infectivity Levels in Primary Swine and Human Respiratory Epithelial Cells

Allen C Bateman 1, Marc G Busch 1, Alexander I Karasin 1, Nicolai Bovin 2, Christopher W Olsen 1,*
PMCID: PMC2519589  PMID: 18550676

Abstract

Avian lineage H4N6 influenza viruses previously isolated from pigs differ at hemagglutinin amino acids 226 and 228 from H4 subtype viruses isolated from birds. Using a parental H4N6 swine isolate and hemagglutinin mutant viruses (at residues 226 and/or 228), we determined that viruses which contain L226 had a higher affinity for sialic acid α2,6 galactose (SAα2,6Gal) and a higher infectivity level for primary swine and human respiratory epithelial cells, whereas viruses which contain Q226 had lower SAα2,6Gal affinity and lower infectivity levels for both types of cells. Using specific neuraminidases, we found that irrespective of their relative binding preferences, all of the influenza viruses examined utilized SAα2,6Gal to infect swine and human cells.


Influenza A viruses are important pathogens of human diseases and those of many other species. All hemagglutinin (HA) and neuraminidase (NA) subtypes of influenza A viruses have been isolated from wild waterfowl (32), but only subtypes H1 to H3 have spread widely among humans, and only subtypes H1 and H3 have circulated in swine populations (33, 46). However, in recent years, both humans and pigs have been infected with avian influenza viruses of multiple subtypes, including H5N1 and H9N2 (22, 36, 49).

One factor believed to be important in determining the influenza virus host range is sialic acid binding preference (14, 26). Avian influenza viruses preferentially bind cell surface sialic acid α2,3 galactose (SAα2,3Gal), whereas human and swine influenza viruses preferentially bind SAα2,6Gal (10, 26, 37, 38). Since swine cells express both SAα2,3Gal and SAα2,6Gal (14) and since avian influenza virus replication in pigs can result in a mutation toward a mammalian-like binding preference (25), it has been postulated that pigs serve as intermediate hosts for the generation of human pandemic viruses (reviewed in references 21, 34, 43, and 46).

Our previous full-length sequence analyses of H4N6 influenza viruses isolated from pigs in Canada revealed that all gene segments were of avian origin, indicative of in toto transmission of an avian virus to pigs (15). Compared to the avian H4 sequences in GenBank, these swine isolates differed at HA amino acids 226 and 228 (H3 numbering [31]). These amino acid positions are major determinants of the binding preference of virus subtypes H2, H3, and H9 (7, 27).

To determine if residues 226 and 228 are important in H4 influenza virus binding, we generated the parental H4N6 swine isolate, A/swine/Ontario/01911-1/99 (rgONT/99) (15), and three HA mutant viruses, in which residues 226 and/or 228 were mutated to avian residues (Table 1), using site-directed mutagenesis and reverse genetics (29). Binding affinities were examined by direct virus binding to biotinylated synthetic glycopolymers as described previously (25), with the modification that viruses were equilibrated to 25,000 copies of matrix gene RNA (19) bound per well. Linear regression analysis of Scatchard plots was performed using Prism software (GraphPad, La Jolla, CA). The Neu5Acα2,3Galβ1-4Glcβ (2,3SL) polymer is widely utilized as the avian-like receptor analog, while the Neu5Acα2,6Galβ1-4GlcNAcβ (2,6SLN) polymer is utilized as the human-like analog (11, 24-26, 35). To ensure that the different polymer backbones (lactose versus lactosamine) did not have major effects on binding affinity, we included 2,3SLN and found that viruses bound to 2,3SL and 2,3SLN with similar levels of affinity (Table 1). The 2,6SL polymer was not used because it is believed not to be an appropriate analog for the human influenza virus receptor (8).

TABLE 1.

Amino acid composition and binding affinity of reverse genetics-generated virusesa

Virus Amino acid composition at:
Polymer binding affinity
HA position 226 HA position 228 2,3SL
2,3SLN
2,6SLN
≈Kd R2 Kd R2 Kd R2
rgONT/99 L S 288 0.88 371 0.90 4 0.99
L226Q Q S 311 0.91 314 0.96 90 0.89
S228G L G 443 0.88 389 0.90 3 1.00
L226Q/S228G Q G 31 0.87 25 0.83 156 0.89
a

Approximate constant of dissociation (≈Kd) values are expressed in nM−1 sialic acid. Lower values indicate higher affinity binding. R2 is the correlation coefficient. Values shown are from one representative experiment, but highly similar results were obtained in repeated experiments.

Based on calculated approximate constants of dissociation (where lower values represent higher affinity), rgONT/99 and the S228G virus had similar binding profiles, with much higher affinity for SAα2,6Gal (2,6SLN) than for SAα2,3Gal (2,3SL and 2,3SLN) (Table 1). The L226Q virus also had a higher affinity for SAα2,6Gal than for SAα2,3Gal, but compared to that of rgONT/99, the L226Q virus had a lower affinity for SAα2,6Gal. The L226Q/S228G virus had an avian-like virus binding preference, with a higher affinity for SAα2,3Gal than for SAα2,6Gal. Taken together, the results indicate that compared to the affinity of rgONT/99, the virus affinity for SAα2,3Gal increases only when amino acids 226 and 228 are both mutated to avian residues, whereas amino acid 226 is the dominant factor in determining the virus' affinity for SAα2,6Gal. This is consistent with data for the H2, H3, and H9 influenza viruses, where amino acid 226 either plays the predominant role (e.g., H2 and H3 [7]) or is solely responsible (e.g., H9 [27]) for sialic acid binding preference.

To determine if changes at amino acids 226 and 228 influence infectivity, we infected primary swine and human respiratory epithelial cells (SRECs and HRECs, respectively) with each of the viruses. We have previously shown that SRECs are a useful system with which to model influenza virus infection of pigs (3), and primary HRECs have been similarly utilized to investigate infections with rhinovirus, respiratory syncytial virus, parainfluenza virus, and influenza A virus (1, 13, 16, 17). Although medium-submerged cell monolayers lack the differentiation of cells grown at an air-liquid interface (12, 28), when these cells are grown as monolayers, they have the necessary receptors and intracellular factors to support influenza A virus infection and replication (3, 13). SRECs and HRECs were grown (3, 40), infected with three 50% tissue culture infective doses (TCID50s)/cell, and stained for the expression of influenza virus nucleoprotein (NP) as described previously (3, 20). By visual inspection of immunocytochemical staining, we determined that the infectivity levels of SRECs and HRECs were similar (Fig. 1). Viruses with L226 infected the majority of the cells, while viruses with Q226 exhibited lower infectivity levels. Detection of NP-positive cells by flow cytometry confirmed this assessment (Fig. 2C and D), demonstrating that amino acid 226 is the major determinant of virus infectivity of SRECs and HRECs.

FIG. 1.

FIG. 1.

Infectivity levels of the H4N6 influenza viruses in SRECs and HRECs. Cells were infected with three TCID50s/cell for each virus, and infected cells were identified by immunocytochemistry (ICC) using the anti-influenza A NP antibody 68D2 (kindly provided by Y. Kawaoka, University of Wisconsin-Madison). Following ICC staining, the brightness and contrast of HREC micrographs were adjusted with ACDSee Photo Editor (ACD Systems) and PowerPoint (Microsoft) software to match that of the SREC micrographs. Similar patterns were observed in repeated experiments and with cells from different pig and human donors. Magnification, ×60.

FIG. 2.

FIG. 2.

Lectin staining and H4N6 influenza virus infectivity after NA depletion of cell surface sialic acid are shown. Removal of sialic acids from the surfaces of SRECs (A) and HRECs (B). Cells were treated with either an α2,3-specific NA or an α2,3/α2,6 NA, followed by cell surface lectin staining with MAA (SAα2,3Gal) or SNA (SAα2,6Gal). Values shown are the geometric means of fluorescent intensity (± standard errors of the means [SEM]) normalized such that the fluorescence intensity of untreated cells is 100% and the fluorescence intensity of mock lectin-treated cells is 0%. Data are the results of four separate experiments performed in duplicate. Virus infectivity levels after NA treatment of SRECs (C) and HRECs (D) are shown. Data are the results of four separate experiments with each virus assayed in triplicate for each experiment. Results are the means ± SEM. Statistically significant differences were observed between the infectivity levels of untreated and α2,3/α2,6 NA-treated cells (analysis of variance-protected Student's t tests; *, P < 0.05; **, P < 0.01).

Although the relative virus infectivity patterns were similar for SRECs and HRECs, the absolute infectivity of each virus was higher for HRECs than for SRECs (Fig. 2C and D). This difference may be due to variations in inner carbohydrate moieties on the cell surface (4, 9), or it could be due to different expression levels of sialic acid species on each cell type. Pigs express both N-acetylneuraminic (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc), whereas humans express only Neu5Ac (5, 44). Infectivity may be dependent upon levels of Neu5Ac, in which case the Neu5Gc on SRECs may lead to a lower expression of Neu5Ac, or it may interfere with the availability of Neu5Ac on SRECs.

To verify the association between binding preference and sialic acid utilization to infect cells, prior to the inoculation of cells with viruses, cells were treated for 3 h with 300 U of either an α2,3-specific NA (Salmonella enterica serovar Typhimurium; New England Biolabs, Beverly, MA) or an NA that removes both α2,3- and α2,6-linked sialic acids (Clostridium perfringens; New England Biolabs). Based on lectin staining (16), we determined that treatment with the α2,3-specific NA decreased the level of α2,3-linked sialic acids on SRECs considerably (with Maackia amurensis agglutinin [MAA; Roche Diagnostics, Mannheim, Germany] staining, to less than 32% of untreated SRECs [Fig. 2A]) without depleting α2,6-linked sialic acids (using Sambucus nigra agglutinin [SNA; Roche Diagnostics, Mannheim, Germany] staining). Treatment with the α2,3/α2,6 NA decreased the level of α2,3- and α2,6-linked sialic acids (with MAA and SNA staining, to less than 23 and 27% of the untreated SRECs, respectively). Similar results were obtained with HRECs (Fig. 2B). However, treatment with the α2,3-specific NA had no effect on the virus infectivity of SRECs or HRECs (Fig. 2C and D), while treatment with the α2,3/α2,6 NA decreased the infectivity of all viruses for both cell types.

The NA treatments did not cleave all of the sialic acids from the cell surfaces, so it is possible that the viruses utilized the remaining α2,3-linked sialic acid to infect cells. However, treatment with the α2,3-specific NA decreased the α2,3-linked sialic acid but not the α2,6-linked sialic acid and resulted in no change in infectivity levels, while treatment with the α2,3/α2,6 NA decreased both the α2,3- and the α2,6-linked sialic acids, and the infectivity levels of all the viruses decreased significantly. This strongly suggests that these viruses do not generally utilize α2,3-linked sialic acid to infect swine or human cells. Instead, all four viruses, independently of their relative binding preferences, preferentially utilized α2,6-linked sialic acid to infect both SRECs and HRECs.

To determine if the changes at amino acids 226 and 228 might represent swine adaptations that occurred after the introduction of an avian influenza virus into pigs, rgONT/99 and the mutant viruses derived from it were serially passaged in SRECs. Cells were initially inoculated with either 0.5 TCID50/cell (with rgONT/99 and the L226Q and S228G viruses) or 2.0 TCID50s/cell (with the L226Q/S228G virus) and incubated with 0.5 μg/ml tolylsulfonyl phenylalanyl chloromethyl ketone-treated trypsin at 37°C for 3 days. The supernatant of each well was then collected, diluted 1:3 in fresh medium, and added to confluent SRECs for the next passage. After 10 passages, the amino acid at position 228 remained unaltered in each virus (Table 2). However, the L226 that was carried initially by some viruses was maintained as L226 throughout, while the Q226 carried initially by other viruses changed to L226 within four passages and was maintained as L226 for the remaining passages. This indicates that the Q226L mutation may represent a swine adaptation. Furthermore, beyond being exclusively a swine adaptation, virus infectivity of HRECs indicates that the Q226L mutation may also be an adaptation used for additional mammalian species.

TABLE 2.

Virus passaging in SRECsa

Passage aa mutations at HA positions for the indicated virus
rgONT/99
L226Q
S228G
L226Q/S228G
aa 226 aa 228 aa 226 aa 228 aa 226 aa 228 aa 226 aa 228
0 L S Q S L G Q G
1 L S Q S L G Q G
2 L S Q/L S L G Q G
3 L S L S L G Q/L G
4 L S L S L G L G
10 L S L S L G L G
a

Amino acid (aa) residues at HA positions 226 and 228 are shown for each virus at each passage. No other mutations in the HA were found upon passaging.

Reassortant H2N3 influenza viruses with an HA of avian lineage have recently been isolated from pigs (23). These viruses had the Q226L mutation in their HA, suggesting that this is a swine adaptation for the H2 subtype viruses as well. Unlike the H4N6 viruses, the H2N3 viruses did not differ from the avian consensus sequence at amino acid 228. However, based on our passage experiments, the G228S mutation found in the H4N6 swine isolates may not be essential for adaptation to pigs.

Polymer binding studies using assays similar to that presented here have been utilized extensively to investigate influenza virus binding preference (10, 18, 24, 25, 27, 35, 47). However, data presented herein suggest that binding preference in such assays does not correlate uniformly with the receptor determinants utilized for infection. The L226Q/S228G virus had a higher affinity for SAα2,3Gal than for SAα2,6Gal, but based on the infectivity level in NA-treated cells, this virus appears to utilize α2,6-linked sialic acids to infect both SRECs and HRECs. This finding has potential implications for other avian influenza virus subtypes. Our results demonstrate that the polymer to which viruses bind with the highest affinity in binding assays may not necessarily be the receptor that the viruses utilize for infection. Therefore, even though α2,3-linked sialic acids are found in the lower human respiratory tract (41, 48) and the H5 influenza viruses can bind to the lower human respiratory tract (45), H5 viruses may still infect human cells via α2,6-linked sialic acids. Indeed, a recent report states that the distribution of SAα2,3Gal in the human respiratory tract is partially inconsistent with the pattern of H5N1-infected cells (48), and Nicholls et al. (30) suggest that binding sites other than SAα2,3Gal may mediate the H5N1 virus infection of human epithelium. In addition to α2,3- and α2,6-linked sialic acids, alternate or coreceptors may also be involved in influenza virus infection, because influenza viruses have been shown to infect desialylated cells (42). The particular proteins or lipids to which sialic acid-containing oligosaccharides are attached are also likely to be important, as cell surface N-linked glycoproteins are necessary for influenza virus infection (6).

Amino acid 226 in the HA of rgONT/99 and related mutant viruses predominantly controls virus affinity for SAα2,6Gal and infectivity of SRECs and HRECs. Independent of binding preference, these viruses appear to utilize α2,6-linked sialic acids to infect both cell types. Thus, in order to establish an efficient infection in pigs, it appears that viruses either must already bind or must rapidly adapt to bind α2,6-linked sialic acids. This finding does not negate the “mixing vessel” hypothesis (39), but it does indicate that a main rationale for this theory (i.e., that pigs express both SAα2,3Gal and SAα2,6Gal) may be less important than previously hypothesized. Pigs still hold considerable potential to serve as mixing vessels, as they are susceptible to both avian and human viruses (2, 34, 46), and viral replication in pigs can lead to a mammalian-like virus binding preference (25). Furthermore, the avian-to-mammalian Q226L mutation that occurred upon virus passage in SRECs suggests that this change is a swine adaptation mutation that may also be an adaptation used for infection of additional species, providing more support for the hypothesis that pigs are an intermediate adaptation host for the generation of pandemic human viruses.

Acknowledgments

We thank G. Landolt for preliminary investigations leading to the present work, M. Suresh for flow cytometry assistance, J. Gern for providing the HRECs, and A. Gambaryan for assistance with the polymer binding assay.

This work was supported by grants from USDA CSREES (2002-02457) and NIH NIAID (R01 AI060646).

Footnotes

Published ahead of print on 11 June 2008.

REFERENCES

  • 1.Becker, S., J. Soukup, and J. R. Yankaskas. 1992. Respiratory syncytial virus infection of human primary nasal and bronchial epithelial cell cultures and bronchoalveolar macrophages. Am. J. Respir. Cell Mol. Biol. 6369-374. [DOI] [PubMed] [Google Scholar]
  • 2.Brown, I. H. 2000. The epidemiology and evolution of influenza viruses in pigs. Vet. Microbiol. 7429-46. [DOI] [PubMed] [Google Scholar]
  • 3.Busch, M. G., A. C. Bateman, G. A. Landolt, A. I. Karasin, R. A. Brockman-Schneider, J. E. Gern, M. Suresh, and C. W. Olsen. 2008. Identification of amino acids in the HA of H3 influenza viruses that determine infectivity levels in primary swine respiratory epithelial cells. Virus Res. 133269-279. [DOI] [PubMed] [Google Scholar]
  • 4.Chandrasekaran, A., A. Srinivasan, R. Raman, K. Viswanathan, S. Raguram, T. M. Tumpey, V. Sasisekharan, and R. Sasisekharan. 2008. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat. Biotechnol. 26107-113. [DOI] [PubMed] [Google Scholar]
  • 5.Chou, H. H., H. Takematsu, S. Diaz, J. Iber, E. Nickerson, K. L. Wright, E. A. Muchmore, D. L. Nelson, S. T. Warren, and A. Varki. 1998. A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc. Natl. Acad. Sci. USA 9511751-11756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Chu, V. C., and G. R. Whittaker. 2004. Influenza virus entry and infection require host cell N-linked glycoprotein. Proc. Natl. Acad. Sci. USA 10118153-18158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Connor, R. J., Y. Kawaoka, R. G. Webster, and J. C. Paulson. 1994. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 20517-23. [DOI] [PubMed] [Google Scholar]
  • 8.Eisen, M. B., S. Sabesan, J. J. Skehel, and D. C. Wiley. 1997. Binding of the influenza A virus to cell-surface receptors: structures of five hemagglutinin-sialyloligosaccharide complexes determined by X-ray crystallography. Virology 23219-31. [DOI] [PubMed] [Google Scholar]
  • 9.Gambaryan, A., S. Yamnikova, D. Lvov, A. Tuzikov, A. Chinarev, G. Pazynina, R. Webster, M. Matrosovich, and N. Bovin. 2005. Receptor specificity of influenza viruses from birds and mammals: new data on involvement of the inner fragments of the carbohydrate chain. Virology 334276-283. [DOI] [PubMed] [Google Scholar]
  • 10.Gambaryan, A. S., A. I. Karasin, A. B. Tuzikov, A. A. Chinarev, G. V. Pazynina, N. V. Bovin, M. N. Matrosovich, C. W. Olsen, and A. I. Klimov. 2005. Receptor-binding properties of swine influenza viruses isolated and propagated in MDCK cells. Virus Res. 11415-22. [DOI] [PubMed] [Google Scholar]
  • 11.Gambaryan, A. S., A. B. Tuzikov, V. E. Piskarev, S. S. Yamnikova, D. K. Lvov, J. S. Robertson, N. V. Bovin, and M. N. Matrosovich. 1997. Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers: non-egg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6′-sialyl(N-acetyllactosamine). Virology 232345-350. [DOI] [PubMed] [Google Scholar]
  • 12.Gray, T. E., K. Guzman, C. W. Davis, L. H. Abdullah, and P. Nettesheim. 1996. Mucociliary differentiation of serially passaged normal human tracheobronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 14104-112. [DOI] [PubMed] [Google Scholar]
  • 13.Hatta, M., Y. Hatta, J. H. Kim, S. Watanabe, K. Shinya, T. Nguyen, P. S. Lien, Q. M. Le, and Y. Kawaoka. 2007. Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog. 31374-1379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Ito, T., J. N. Couceiro, S. Kelm, L. G. Baum, S. Krauss, M. R. Castrucci, I. Donatelli, H. Kida, J. C. Paulson, R. G. Webster, and Y. Kawaoka. 1998. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J. Virol. 727367-7373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Karasin, A. I., I. H. Brown, S. Carman, and C. W. Olsen. 2000. Isolation and characterization of H4N6 avian influenza viruses from pigs with pneumonia in Canada. J. Virol. 749322-9327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kogure, T., T. Suzuki, T. Takahashi, D. Miyamoto, K. I. Hidari, C. T. Guo, T. Ito, Y. Kawaoka, and Y. Suzuki. 2006. Human trachea primary epithelial cells express both sialyl(alpha2-3)Gal receptor for human parainfluenza virus type 1 and avian influenza viruses, and sialyl(alpha2-6)Gal receptor for human influenza viruses. Glycoconj. J. 23101-106. [DOI] [PubMed] [Google Scholar]
  • 17.Kong, X., H. San Juan, M. Kumar, A. K. Behera, A. Mohapatra, G. R. Hellermann, S. Mane, R. F. Lockey, and S. S. Mohapatra. 2003. Respiratory syncytial virus infection activates STAT signaling in human epithelial cells. Biochem. Biophys. Res. Commun. 306616-622. [DOI] [PubMed] [Google Scholar]
  • 18.Kumari, K., S. Gulati, D. F. Smith, U. Gulati, R. D. Cummings, and G. M. Air. 2007. Receptor binding specificity of recent human H3N2 influenza viruses. Virol. J. 442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Landolt, G. A., A. I. Karasin, C. Hofer, J. Mahaney, J. Svaren, and C. W. Olsen. 2005. Use of real-time reverse transcriptase polymerase chain reaction assay and cell culture methods for detection of swine influenza A viruses. Am. J. Vet. Res. 66119-124. [DOI] [PubMed] [Google Scholar]
  • 20.Landolt, G. A., A. I. Karasin, L. Phillips, and C. W. Olsen. 2003. Comparison of the pathogenesis of two genetically different H3N2 influenza A viruses in pigs. J. Clin. Microbiol. 411936-1941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Landolt, G. A., and C. W. Olsen. 2007. Up to new tricks—a review of cross-species transmission of influenza A viruses. Anim. Health Res. Rev. 81-21. [DOI] [PubMed] [Google Scholar]
  • 22.Lin, Y. P., M. Shaw, V. Gregory, K. Cameron, W. Lim, A. Klimov, K. Subbarao, Y. Guan, S. Krauss, K. Shortridge, R. Webster, N. Cox, and A. Hay. 2000. Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc. Natl. Acad. Sci. USA 979654-9658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ma, W., A. L. Vincent, M. R. Gramer, C. B. Brockwell, K. M. Lager, B. H. Janke, P. C. Gauger, D. P. Patnayak, R. J. Webby, and J. A. Richt. 2007. Identification of H2N3 influenza A viruses from swine in the United States. Proc. Natl. Acad. Sci. USA 10420949-20954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Matrosovich, M., T. Matrosovich, J. Uhlendorff, W. Garten, and H. D. Klenk. 2007. Avian-virus-like receptor specificity of the hemagglutinin impedes influenza virus replication in cultures of human airway epithelium. Virology 361384-390. [DOI] [PubMed] [Google Scholar]
  • 25.Matrosovich, M., A. Tuzikov, N. Bovin, A. Gambaryan, A. Klimov, M. R. Castrucci, I. Donatelli, and Y. Kawaoka. 2000. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J. Virol. 748502-8512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Matrosovich, M. N., A. S. Gambaryan, S. Teneberg, V. E. Piskarev, S. S. Yamnikova, D. K. Lvov, J. S. Robertson, and K. A. Karlsson. 1997. Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site. Virology 233224-234. [DOI] [PubMed] [Google Scholar]
  • 27.Matrosovich, M. N., S. Krauss, and R. G. Webster. 2001. H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity. Virology 281156-162. [DOI] [PubMed] [Google Scholar]
  • 28.Matrosovich, M. N., T. Y. Matrosovich, T. Gray, N. A. Roberts, and H. D. Klenk. 2004. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl. Acad. Sci. USA 1014620-4624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Neumann, G., T. Watanabe, H. Ito, S. Watanabe, H. Goto, P. Gao, M. Hughes, D. R. Perez, R. Donis, E. Hoffmann, G. Hobom, and Y. Kawaoka. 1999. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. USA 969345-9350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Nicholls, J. M., M. C. Chan, W. Y. Chan, H. K. Wong, C. Y. Cheung, D. L. Kwong, M. P. Wong, W. H. Chui, L. L. Poon, S. W. Tsao, Y. Guan, and J. S. Peiris. 2007. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat. Med. 13147-149. [DOI] [PubMed] [Google Scholar]
  • 31.Nobusawa, E., T. Aoyama, H. Kato, Y. Suzuki, Y. Tateno, and K. Nakajima. 1991. Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 182475-485. [DOI] [PubMed] [Google Scholar]
  • 32.Olsen, B., V. J. Munster, A. Wallensten, J. Waldenstrom, A. D. Osterhaus, and R. A. Fouchier. 2006. Global patterns of influenza A virus in wild birds. Science 312384-388. [DOI] [PubMed] [Google Scholar]
  • 33.Olsen, C. W. 2002. The emergence of novel swine influenza viruses in North America. Virus Res. 85199-210. [DOI] [PubMed] [Google Scholar]
  • 34.Olsen, C. W., I. H. Brown, B. C. Easterday, and K. van Reeth. 2006. Swine influenza, p. 469-482. In B. E. Straw, J. J. Zimmerman, S. D. D'Allaire, and D. J. Taylor (ed.), Diseases of swine, 9th ed. Iowa State Press, Ames, IA.
  • 35.Owen, R. E., E. Yamada, C. I. Thompson, L. J. Phillipson, C. Thompson, E. Taylor, M. Zambon, H. M. Osborn, W. S. Barclay, and P. Borrow. 2007. Alterations in receptor binding properties of recent human influenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells. J. Virol. 8111170-11178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Peiris, J. S., Y. Guan, D. Markwell, P. Ghose, R. G. Webster, and K. F. Shortridge. 2001. Cocirculation of avian H9N2 and contemporary “human” H3N2 influenza A viruses in pigs in southeastern China: potential for genetic reassortment? J. Virol. 759679-9686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Rogers, G. N., and B. L. D'Souza. 1989. Receptor binding properties of human and animal H1 influenza virus isolates. Virology 173317-322. [DOI] [PubMed] [Google Scholar]
  • 38.Rogers, G. N., and J. C. Paulson. 1983. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 127361-373. [DOI] [PubMed] [Google Scholar]
  • 39.Scholtissek, C., H. Burger, O. Kistner, and K. F. Shortridge. 1985. The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses. Virology 147287-294. [DOI] [PubMed] [Google Scholar]
  • 40.Schroth, M. K., E. Grimm, P. Frindt, D. M. Galagan, S. I. Konno, R. Love, and J. E. Gern. 1999. Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 201220-1228. [DOI] [PubMed] [Google Scholar]
  • 41.Shinya, K., M. Ebina, S. Yamada, M. Ono, N. Kasai, and Y. Kawaoka. 2006. Avian flu: influenza virus receptors in the human airway. Nature 440435-436. [DOI] [PubMed] [Google Scholar]
  • 42.Stray, S. J., R. D. Cummings, and G. M. Air. 2000. Influenza virus infection of desialylated cells. Glycobiology 10649-658. [DOI] [PubMed] [Google Scholar]
  • 43.Subbarao, K., D. Swayne, and C. W. Olsen. 2005. Epidemiology and control of human and animal influenza, p. 229-280. In Y. Kawaoka (ed.), Influenza virology: current topics. Caister Academic Press, Wymondham, England.
  • 44.Suzuki, T., G. Horiike, Y. Yamazaki, K. Kawabe, H. Masuda, D. Miyamoto, M. Matsuda, S. I. Nishimura, T. Yamagata, T. Ito, H. Kida, Y. Kawaoka, and Y. Suzuki. 1997. Swine influenza virus strains recognize sialylsugar chains containing the molecular species of sialic acid predominantly present in the swine tracheal epithelium. FEBS Lett. 404192-196. [DOI] [PubMed] [Google Scholar]
  • 45.van Riel, D., V. J. Munster, E. de Wit, G. F. Rimmelzwaan, R. A. Fouchier, A. D. Osterhaus, and T. Kuiken. 2006. H5N1 virus attachment to lower respiratory tract. Science 312399. [DOI] [PubMed] [Google Scholar]
  • 46.Webster, R. G., W. J. Bean, O. T. Gorman, T. M. Chambers, and Y. Kawaoka. 1992. Evolution and ecology of influenza A viruses. Microbiol. Rev. 56152-179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Wu, W., and G. M. Air. 2004. Binding of influenza viruses to sialic acids: reassortant viruses with A/NWS/33 hemagglutinin bind to alpha2,8-linked sialic acid. Virology 325340-350. [DOI] [PubMed] [Google Scholar]
  • 48.Yao, L., C. Korteweg, W. Hsueh, and J. Gu. 2008. Avian influenza receptor expression in H5N1-infected and noninfected human tissues. FASEB J. 22733-740. [DOI] [PubMed] [Google Scholar]
  • 49.Zhu, Q., H. Yang, W. Chen, W. Cao, G. Zhong, P. Jiao, G. Deng, K. Yu, C. Yang, Z. Bu, Y. Kawaoka, and H. Chen. 2008. A naturally occurring deletion in its NS gene contributes to the attenuation of an H5N1 swine influenza virus in chickens. J. Virol. 82220-228. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES